Close

Rating History for Karyopharm Therapeutics (KPTI) by Morgan Stanley

More Stocks Rated by Morgan Stanley | Latest Ratings for KPTI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/7/2023 Michael Ulz Maintain Equalweight
(N/A)		 4.00
(5.00)		  
 		   Details